Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Fuqua

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|February 3, 1993
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancerD C Allred, G M Clark, R Elledge, et al.
Molecular Endocrinology (Baltimore, Md.)|March 9, 2000
Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivationS Oesterreich, Q Zhang, T Hopp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patientsS Oesterreich, S G Hilsenbeck, D R Ciocca, et al.
Cancer Research|January 1, 1991
Variant human breast tumor estrogen receptor with constitutive transcriptional activityS A Fuqua, S D Fitzgerald, G C Chamness, et al.
Cancer Research|August 15, 1997
MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifenN Brünner, B Boysen, S Jirus, et al.
The EMBO Journal|March 15, 1994
The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancerD Stein, J Wu, S A Fuqua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancerP M Ravdin, A K Tandon, D C Allred, et al.
Breast Cancer Research and Treatment|January 1, 1993
The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domainS A Fuqua, D C Allred, R M Elledge, et al.
Cancer Research|January 15, 1992
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumorsS A Fuqua, S D Fitzgerald, D C Allred, et al.
Cancer Research|August 17, 2000
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesionsS A Fuqua, C Wiltschke, Q X Zhang, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|February 3, 1993
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancerD C Allred, G M Clark, R Elledge, et al.
Molecular Endocrinology (Baltimore, Md.)|March 9, 2000
Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivationS Oesterreich, Q Zhang, T Hopp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patientsS Oesterreich, S G Hilsenbeck, D R Ciocca, et al.
Cancer Research|January 1, 1991
Variant human breast tumor estrogen receptor with constitutive transcriptional activityS A Fuqua, S D Fitzgerald, G C Chamness, et al.
Cancer Research|August 15, 1997
MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifenN Brünner, B Boysen, S Jirus, et al.
The EMBO Journal|March 15, 1994
The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancerD Stein, J Wu, S A Fuqua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancerP M Ravdin, A K Tandon, D C Allred, et al.
Breast Cancer Research and Treatment|January 1, 1993
The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domainS A Fuqua, D C Allred, R M Elledge, et al.
Cancer Research|January 15, 1992
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumorsS A Fuqua, S D Fitzgerald, D C Allred, et al.
Cancer Research|August 17, 2000
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesionsS A Fuqua, C Wiltschke, Q X Zhang, et al.
Pageof 9